By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Concert Pharmaceuticals, Inc. 

99 Hayden Avenue
Suite 500
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-860-0045 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Concert Pharmaceuticals, Inc. (CNCE) Initiates Phase 1 Trial Of CTP-543 As A New Treatment For Alopecia Areata 5/19/2016 10:53:30 AM
Concert Pharmaceuticals, Inc. (CNCE) To Present At Several Upcoming Investor Conferences 5/17/2016 11:07:50 AM
Concert Pharmaceuticals, Inc. (CNCE) Unveils CTP-543 For Treatment Of Alopecia Areata 5/5/2016 10:49:49 AM
Concert Pharmaceuticals, Inc. (CNCE) Reports First Quarter 2016 Financial Results 5/5/2016 9:48:52 AM
Concert Pharmaceuticals, Inc. (CNCE) Announces Positive Data From Multiple Dose Phase 1 Clinical Trial Of CTP-656, Lead Candidate For The Treatment Of Cystic Fibrosis 4/29/2016 10:08:02 AM
Concert Pharmaceuticals, Inc. (CNCE) To Report First Quarter 2016 Financial Results On May 5, 2016 4/28/2016 12:07:23 PM
Concert Pharmaceuticals, Inc. (CNCE) Names Christine van Heek To Board Of Directors 4/14/2016 10:49:41 AM
Concert Pharmaceuticals, Inc. (CNCE) Names Meghan Fitzgerald To Its Board Of Directors 3/23/2016 9:10:09 AM
Concert Pharmaceuticals, Inc. (CNCE) Announces CTP-656 Solid Dose Phase 1 Results Confirmed Superior Pharmacokinetic Profile To Kalydeco 3/1/2016 11:39:54 AM
Concert Pharmaceuticals, Inc. (CNCE) Reports Fourth Quarter And Year Ended 2015 Financial Results 3/1/2016 11:36:25 AM
12345678910...
//-->